Evaluation of Adherence and Cost Effectiveness of Antilipidemic and Antidiabetic Medications at Tertiary Care Hospital of Hyderabad, Pakistan

Interventional study on three hundred cardiac and diabetic patients was performed. Patients with age of 20-70 years and taking either antilipidemic and anti-diabetic were evaluated by using the questionnaire. Patients were counseled about importance of appropriate medication and its effects were monitored after six months of counseling. Out of 300, male and female patients were 167 (55.7%) and 133 (44.3%), respectively, with age of 59.5 +/- 9.6 years. Over all drug adherence was high 87 (29.0%), moderate 67 (223%), and low 146 (48.7%). Drug adherence was high 27 (27.0%), 30 (30.0%), and 30 (30.0%), moderate 24 (24.0%), 26 (26.0%), and 17 (17.0%) and low 49 (49.0%), 44 (44.0%), and 53 (53.0%) in hyperlipidemic, diabetic and hyperlipidemic with diabetic, respectively. Cost effective treatment was niacin in hyperlipidemic, glipizide in diabetic and metformin with atorvastatin in hyperlipidemic with diabetic patients respectively. Drug adherence was low that increased with proper counseling by pharmacists and affordable prescribing.